Miroslava Blechová

Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration

Veronika Nagelová, Anežka Tichá, Jana Zemenová et al. · International Journal of Obesity · 2015 · 66 citations

Obesity, Metabolic Syndrome, Peripheral Administration +12

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity

Veronika Pražienková, Martina Holubová, Helena Pelantová et al. · PLoS ONE · 2017 · 49 citations · Full text

Prrp Receptor Gpr10, Peptide Science, Peptide Therapeutics +22

The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity

Resha Matyšková, Jana Maixnerová, David Sýkora et al. · Molecular and Cellular Endocrinology · 2011 · 44 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Disorder +13

Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration

Lenka Maletı́nská, Anežka Tichá, Veronika Nagelová et al. · Brain Research · 2013 · 39 citations

Neuropeptides, Peripheral Administration, Gastrointestinal Peptide Hormone +12

Structure–activity relationship of CART (cocaine- and amphetamine-regulated transcript) peptide fragments

Jana Maixnerová, Jan Hlaváček, Darja Blokešová et al. · Peptides · 2007 · 29 citations

Molecular Pharmacology, Biochemistry, Natural Sciences +8